Keeping Track: Immunology In Focus As US FDA Approves Kevzara, New Breakthrough Actemra Use; J&J, Sun Advance Psoriasis Candidates

 
• By Bridget Silverman

The latest immunology drug development news and highlights from our FDA Performance Tracker.

Keeping Track Feature image

More from Approvals

More from Product Reviews